132 related articles for article (PubMed ID: 24684186)
1. Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis.
Sellner J; Davies NW; Howard RS; Petzold A
Eur J Neurol; 2014 Jun; 21(6):845-50. PubMed ID: 24684186
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury.
Rejdak K; Kuhle J; Rüegg S; Lindberg RL; Petzold A; Sulejczak D; Papuc E; Rejdak R; Stelmasiak Z; Grieb P
Epilepsia; 2012 May; 53(5):922-7. PubMed ID: 22509781
[TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection.
Petzold A; Groves M; Leis AA; Scaravilli F; Stokic DS
Muscle Nerve; 2010 Jan; 41(1):42-9. PubMed ID: 19790244
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
[TBL] [Abstract][Full Text] [Related]
6. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.
Petzold A; Michel P; Stock M; Schluep M
J Stroke Cerebrovasc Dis; 2008; 17(4):196-203. PubMed ID: 18589339
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy.
Petzold A; Thompson EJ; Keir G; Quinn N; Holmberg B; Dizdar N; Wenning GK; Rascol O; Tolosa E; Rosengren L
J Neurol Sci; 2009 Apr; 279(1-2):76-9. PubMed ID: 19195665
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
9. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.
Petzold A; Eikelenboom MJ; Keir G; Grant D; Lazeron RH; Polman CH; Uitdehaag BM; Thompson EJ; Giovannoni G
J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):206-11. PubMed ID: 15654034
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
[TBL] [Abstract][Full Text] [Related]
11. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome.
Petzold A; Brettschneider J; Jin K; Keir G; Murray NM; Hirsch NP; Itoyama Y; Reilly MM; Takeda A; Tumani H
Muscle Nerve; 2009 Jul; 40(1):42-9. PubMed ID: 19533642
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
13. Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barré syndrome.
Dujmovic I; Lunn MP; Reilly MM; Petzold A
Muscle Nerve; 2013 Jul; 48(1):132-4. PubMed ID: 23716297
[TBL] [Abstract][Full Text] [Related]
14. Axonal damage and outcome in subarachnoid haemorrhage.
Petzold A; Keir G; Kay A; Kerr M; Thompson EJ
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):753-9. PubMed ID: 16705199
[TBL] [Abstract][Full Text] [Related]
15. Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.
Pouw MH; Kwon BK; Verbeek MM; Vos PE; van Kampen A; Fisher CG; Street J; Paquette SJ; Dvorak MF; Boyd MC; Hosman AJ; van de Meent H
Spinal Cord; 2014 Jun; 52(6):428-33. PubMed ID: 24710150
[TBL] [Abstract][Full Text] [Related]
16. Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.
Al Nimer F; Thelin E; Nyström H; Dring AM; Svenningsson A; Piehl F; Nelson DW; Bellander BM
PLoS One; 2015; 10(7):e0132177. PubMed ID: 26136237
[TBL] [Abstract][Full Text] [Related]
17. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.
Pranzatelli MR; Tate ED; McGee NR; Verhulst SJ
J Neuroimmunol; 2014 Jan; 266(1-2):75-81. PubMed ID: 24342231
[TBL] [Abstract][Full Text] [Related]
18. Axonal pathology in subarachnoid and intracerebral hemorrhage.
Petzold A; Rejdak K; Belli A; Sen J; Keir G; Kitchen N; Smith M; Thompson EJ
J Neurotrauma; 2005 Mar; 22(3):407-14. PubMed ID: 15785235
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients.
Rommer PS; Kamin F; Petzold A; Tumani H; Abu-Mugheisib M; Koehler W; Hoffmann F; Winkelmann A; Benecke R; Zettl UK
Mol Diagn Ther; 2014 Dec; 18(6):631-7. PubMed ID: 24986188
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
